Companies: 10,795·Total market cap: $144.5T
Amplitude Healthcare Acquisition Corporation

Amplitude Healthcare Acquisition Corporation

AMHCNASDAQFinancial Services
$10.23
$-0.42(-3.94%)
Market Cap$1.1B
P/E Ratio
52W High$11.44
52W Low$10.0001

Amplitude Healthcare Acquisition Corporation (AMHC) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

amhc · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Amplitude Healthcare Acquisition Corporation (AMHC) measures how much investors pay for each dollar of the company's trailing earnings. AMHC's current PE ratio of N/A is calculated by dividing its stock price of $10.23 by its TTM earnings per share of $0.00.

N/A
P/E Ratio (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
EPS (TTM)
$0.00
TTM · diluted EPS
PEG Ratio
0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Amplitude Healthcare Acquisition Corporation SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2020 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Shell Companies · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Amplitude Healthcare Acquisition Corporation
Amplitude Healthcare Acquisition CorporationYou
AMHC
$1.1BN/A$0.00
Social Capital Suvretta Holdings Corp. I
Social Capital Suvretta Holdings Corp. I
DNAA
$1.1BN/A$0.00
FG New America Acquisition Corp.
FG New America Acquisition Corp.
FGNA
$1.1B1.81x-90.1%$5.52
FTAC Hera Acquisition Corp.
FTAC Hera Acquisition Corp.
HERA
$1.1B34.54x+90.1%$0.28
Humacyte, Inc.
Humacyte, Inc.
HUMA
$232MN/A-$0.26
LifeSci Acquisition II Corp.
LifeSci Acquisition II Corp.
LSAQ
$1.1BN/A
TPG Pace Tech Opportunities Corp.
TPG Pace Tech Opportunities Corp.
PACE
$1.1BN/A-$0.33
Industry Average
2 peers with valid PE
18.17xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 3 of 3 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$0.00
2024-12-31
FY2024
$0.00
2020-12-31
FY2020
$-0.05

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Amplitude Healthcare Acquisition Corporation (AMHC) measures how much investors pay for each dollar of the company's trailing earnings. AMHC's current PE ratio of N/A is calculated by dividing its stock price of $10.23 by its TTM earnings per share of $0.00.

PE Ratio = Stock Price ÷ EPS (TTM)
= $10.23 ÷ $0.00 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

AMHC pe ratio · 6 questions

AMHC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $10.23 and TTM EPS of $0.00. Data sourced from Financial Modeling Prep via AMHC's SEC 10-K and 10-Q filings.

AMHC PE ratioWhat is AMHC PE ratioCurrent PE ratio of AMHCAMHC PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Amplitude Healthcare Acquisition Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09